Announced
Completed
Otium Capital led a €16m Series A round in BeFC Bioenzymatic.
Financials
Transaction Value£13m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
Minority
Single Bidder
Domestic
Private
Renewable Energy Equipment
France
renewable energy
Acquisition
Private Equity
Friendly
Venture Capital
Completed
Synopsis
Otium Capital, an investment company, led a €16m Series A round in BeFC Bioenzymatic, a renewable energy semiconductor manufacturing, with participation from Demeter, BNP Paribas Développement and Supernova Invest.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.